In adolescent females, CYP19A1 is predominantly expressed in the ovaries, and letrozole effectively induces ovarian dysfunction associated with impaired aromatase activity, resulting in PCOS-like pathologies. This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.